BIOPOR — BioPorto A/S Income Statement
0.000.00%
Last trade - 00:00- DKK650.16m
- DKK627.55m
- DKK36.24m
Annual income statement for BioPorto A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 23.2 | 24.3 | 29 | 31 | 36.2 |
| Cost of Revenue | |||||
| Gross Profit | 13.3 | 15 | 19 | 20.2 | 24.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 86.8 | 89.5 | 110 | 92.1 | 112 |
| Operating Profit | -63.6 | -65.3 | -81.5 | -61.2 | -75.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -66.8 | -63.8 | -81.5 | -61.2 | -73.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -61.6 | -57.1 | -75.9 | -56.3 | -68.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -61.6 | -57.1 | -75.9 | -56.3 | -68.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -61.6 | -57.1 | -75.9 | -56.3 | -68.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.288 | -0.205 | -0.224 | -0.155 | -0.168 |
| Dividends per Share |